Home > Formulary : Adult > Chapters > 10. Musculoskeletal and Joint Diseases >
BNSSG Adult Joint Formulary
10.4 Pain and inflammation in musculoskeletal disorders
Last edited: 11-01-2024
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Non-steroidal anti-inflammatory drugs
- See MHRA guidance on Cardiovascular Safety of Cox-2 inhibitors and non-selective NSAIDs
- Please also refer to NICE NG226 and NICE NG100
- Healthcare professionals should consider offering paracetamol for pain relief in addition to core treatments; regular dosing may be required. Paracetamol and/or topical non-steroidal anti-inflammatory drugs (NSAIDs) should be considered ahead of oral NSAIDs, cyclooxygenase 2 (COX-2) inhibitors or opioids
- The combination of a NSAID and low-dose aspirin can increase the risk of gastrointestinal side-effects; this combination should be used only if absolutely necessary and the patient should be monitored closely
- NSAIDs should be used at the lowest effective dose and long term use should be avoided
Ibuprofen (TLS Green)
Naproxen (TLS Green)
Alternatives: (TLS Blue)
Diclofenac
Indometacin
Nabumetone
Mefenamic acid
- Menorrhagia / dysmenorrhoea
Meloxicam
Etodolac
Celecoxib
Etoricoxib
Ketorolac
- For use by anaesthetic staff only
Topical NSAIDs
Recommended: (TLS Green)
Ibuprofen 5% gel - use should be reviewed after 14 days
Alternative: (TLS Blue)
Piroxicam 0.5% gel
Contact Us
Got a question or comment about the Joint Formulary?
Please use the email address below to contact us and we will endeavour to respond within 2 working days.